Skip to content

PC-300 Tea Effect on Triglyceride Levels

Eryngium Heterophyllum + Amphipterygium Adstringens Tea Effect on Triglyceride Levels

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03649269
Enrollment
34
Registered
2018-08-28
Start date
2014-01-01
Completion date
2014-12-31
Last updated
2018-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertriglyceridemia

Keywords

Eryngium heterophyllum, Amphipterygium adstringens, tea

Brief summary

Herbal medicine represents an alternative for treating dyslipidemia. The aim of this project was to evaluate the PC-300 tea (Eryngium heterophyllum egelm + Amphipterygium adstringens) against hypertriglyceridemia. Baseline samples of serum total cholesterol and triglycerides were obtained and measured again after 1 month of treatment with the following two alternatives: 1) PC-300, one cup half an hour before eating, and 2) bezafibrate 200 mg/d.

Detailed description

It was a descriptive, prospective, longitudinal, and comparative clinical study developed at Ciprés Grupo Médico S.C. (CGM), Toluca, Mexico, from January 2014 to December 2014. Patients with hypertriglyceridemia were invited to participate in the study. Voluntary subjects were assigned sequentially into two treatment groups: 1) fibrate (bezafibrate) 200 mg/day, and 2) PC-300 tea, one cup half an hour before eating. Patients were measured (m) and weighed (kg) (Obi, México). Body mass index (BMI) was calculated as weight (kg) divided by height (m) squared. Blood pressure was measured with a calibrated sphygmomanometer (Welch Allyn, USA) after 5 min of rest. All of the patients were given a low lipid diet. Calculated kcal were based on ideal weight minus 200 kcal/day if overweight. Results were expressed as mean ± Standard deviation (SD). Differences between initial vs. final values were compared with the Mann-Whitney U test. The normality hypothesis was tested using the Kolmogorov-Smirnov test. A p value of \<0.05 was considered significant. All tests were performed with the SPSS ver. 23 statistical software program.

Interventions

DIETARY_SUPPLEMENTPC-300 tea.

Patients had to drink one cup of the tea half an hour before breakfast, main meal and dinner.

Patients were prescribed 200 mg/day at night.

Sponsors

Ciprés Grupo Médico CGM SC
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Voluntary subjects were assigned sequentially into two treatment groups: 1) fibrate (bezafibrate) 200 mg/day, and 2) PC-300 tea, one cup half an hour before eating.

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients with hypertriglyceridemia, aged \>18 years and with an educational level at least of primary school.

Exclusion criteria

* Patients with hepatic disease and those missing an appointment during the study.

Design outcomes

Primary

MeasureTime frameDescription
Triglycerides serum levels.One month.The triglycerides serum levels were measured at the recruiting moment and after one month..

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026